Research Topics
Species | M SteurerSummaryAffiliation: University of Innsbruck Country: Austria Publications
| Collaborators
|
Detail Information
Publications
Large-vessel arteritis and myelodysplastic syndrome: report of two casesM Steurer
Division of Haematology and Oncology, Innsbruck University Hospital, Innsbruck, Austria
Eur J Haematol 73:128-33. 2004..In this clinical setting, steroid therapy may alleviate inflammatory symptoms and result in beneficial hematologic responses...- Prevalence and management of anaemia in haematologic cancer patients receiving cyclic nonplatinum chemotherapy: results of a prospective national chart surveyMichael Steurer
Division of Haematology and Oncology, Innsbruck University Hospital, Innsbruck, Austria
Wien Klin Wochenschr 116:367-72. 2004..Predictive factors for anaemia development and anaemia treatment were also assessed... - Low-dose thalidomide for multiple myeloma: interim analysis of a compassionate use programM Steurer
Abteilung für Hämatologie and Onkologie, Universitatsklinik fur Innere Medizin, Innsbruck, Austria
Onkologie 27:150-4. 2004..Novel therapeutic approaches are thus needed. Thalidomide has recently been recognized as an effective new agent for previously untreated, refractory or relapsed myeloma... - Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysisMichael Steurer
Innsbruck Medical University, Division of Hematology and Oncology, Anichstrasse 35, A 6020 Innsbruck, Austria
Cancer Treat Rev 32:377-89. 2006..However, none was able to show a survival advantage. Thus, a systematic Cochrane review may be able to further define the role of purine analogues in the first-line treatment of B-CLL... - Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alphaMichael Steurer
Division of Haematology and Oncology, Innsbruck University Hospital, Anichstrasse 35, A 6020 Innsbruck, Austria
Br J Haematol 121:101-3. 2003..Careful clinical surveillance and thrombosis prophylaxis (heparin or oral anticoagulation) should be considered for MDS patients undergoing combined treatment with thalidomide and erythropoietic growth factors... - Purine antagonists for chronic lymphocytic leukaemiaM Steurer
Innsbruck University Hospital, Division of Haematology and Oncology, Anichstrasse 35, A 6020 Innsbruck, Austria
Cochrane Database Syst Rev 3:CD004270. 2006..Recent trials suggest improved response rates for purine antagonists compared to alkylator-based regimens in the treatment of B-CLL. However, none was able to show a survival advantage... - Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevanceD Fong
Division of Hematology and Oncology, Innsbruck Medical University, Austria
J Clin Pathol 61:31-5. 2008..Thus, the aim of this study was to investigate Ep-CAM expression and its potential prognostic impact in pancreatic and ampullary carcinomas... 
Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survivalG Spizzo
Division of Haematology and Oncology, University of Innsbruck, Austria
Br J Cancer 88:574-8. 2003..7% of tumour specimens and had an additive negative impact on disease-free and overall survival. Determination of both tumour markers should help in guiding new therapeutic strategies in patients with invasive breast cancer...- Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasiaKathrin Strasser-Weippl
First Medical Department, Center for Oncology and Hematology, Wilhelminen Hospital, Vienna, Austria
Cancer 107:2801-6. 2006..Rare abnormalities confer an adverse outcome, but the main recurrent chromosomal aberrations do not correlate with clinical features and prognosis... - Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic scoreKathrin Strasser-Weippl
First Medical Department with Medical Oncology, Wilhelminen Hospital, Vienna, Austria
Leuk Lymphoma 47:441-50. 2006..This is in contrast to previous prognostic scores, in which the poor prognosis group was often very small and/or could not be consistently differentiated from patients with an intermediate prognosis... - Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patientsDominik Wolf
Department of Hematology and Oncology, Innsbruck Medical University, Anichstr 35, 6020 Innsbruck, Austria
Cancer Immunol Immunother 55:1198-208. 2006..It remains unclear whether this is due to redistribution or active proliferation. The latter would require the upregulation of telomerase activity, whose regulation also remains unknown for Treg... - Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantationMichael Steurer
Division of Haematology and Oncology, University Hospital Innsbruck, Austria
Hum Pathol 33:253-8. 2002..Moreover, HSTCL seems to occur as a specific late complication of solid organ transplantation... - Idiopathic myelofibrosis with nodal, serosal and parenchymatous infiltration. Case report and review of the literatureAlexander Tzankov
Institute of Pathology, University of Innsbruck, Austria
Acta Haematol 107:173-6. 2002..The present case demonstrates that IMF not only can progress to acute leukemia but can also spread uncontrollably, or 'metastasize' with extensive sclerosing hematopoietic tumors throughout the body... - Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profileMichael Steurer
Division of Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria
Cancer 101:2239-46. 2004..CONCLUSIONS: Anagrelide was an effective and well tolerated treatment modality for reducing platelet counts in both newly diagnosed and pretreated patients with thrombocytosis due to myeloproliferative disorders... - Improving tumor cell detection in pleural effusions by interphase cytogeneticsMichael Fiegl
Cytometry B Clin Cytom 55:60-2. 2003 - Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximabMichael Steurer
Transplantation 76:435-6. 2003 - Increase of regulatory T cells in the peripheral blood of cancer patientsAnna Maria Wolf
Institute for Biomedical Aging Research, Austrian Academy of Sciences, 6020 Innsbruck, Austria
Clin Cancer Res 9:606-12. 2003..Experimental tumor models in mice revealed that Tregs are potent inhibitors of an antitumor immune response. The current study was designed to determine whether cancer patients exhibit an expanded Treg pool... - Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factorMichael Steurer
Division of Haematology and Oncology, Innsbruck Medical University, Innsbruck, Austria
Hum Pathol 38:1057-64. 2007..Moreover, we found significantly elevated VEGF expression correlating with MVD, thus suggesting VEGF to play a prominent angiogenic role and representing a novel potential therapeutic target in CIMF... - The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formationGerold Untergasser
Tumor Biology and Angiogenesis Laboratory, Division of Hematology and Oncology, Innsbruck Medical University, Innsbruck, Austria
Int J Cancer 122:1539-47. 2008..Thus, we postulate a novel function of Dkk-3 in endothelial cells as a differentiation factor involved in remodeling the tumor vasculature...